Theophylline is an effective bronchodilator at therapeutic levels but
administration of excessive amounts may produce serious toxicity
including arrhythmias, seizures and death(1). We conducted a
descriptive study during October-December 2002 on children presenting
with acute respiratory infection (ARI) and CNS excitation symptoms to
find out the cause for CNS excitation symptoms. The age, sex, clinical
manifestations, concurrent medical illness and medications were
recorded. Serum theophylline level samples were collected as soon as
child arrived in emergency department in addition to serum
electrolytes, serum calcium, CSF analysis and chest radiograph. Serum
theophylline levels were determined by high-performance liquid
chromatography (HPLC).
During the study period, a total of 10 children
presented with acute respiratory infection and CNS excitation
symptoms. 6 cases had evidence of acute theophylline over dosage. The
clinical features of these children are given in Table I. The
most common manifestations were irritability (100%), tremors (83.3%),
seizures (66.6%), and vomiting (50%). Tachycardia and tachypnea were
seen in all children. Hyperglycemia was seen in 2 (33%) children. All
these 6 children had received theophylline preparations by local
practitioners before admission. Out of the remaining 4 children, 2 had
hypoxic seizures, one had acute CNS infection and one had probable
inborn error of metabolism.
TABLE I
Clinical Profile and Investigations of Children with LRI and Theophylline Overdosage
|
Case 1 |
Case 2 |
Case 3 |
Case 4 |
Case 5 |
Case 6 |
% |
Age |
45 days |
50 days |
75 days |
65 days |
90 days |
70 days
|
|
Sex
|
Male |
Female |
Male |
Male |
Male |
Male |
Male |
Irritability
|
+
|
+
|
+
|
+
|
+
|
+
|
100
|
Tremors
|
+
|
+
|
-
|
+
|
+
|
+
|
83
|
Seizures
|
+
|
+
|
+
|
+
|
-
|
-
|
67
|
Vomiting
|
-
|
-
|
+
|
-
|
+
|
+
|
50
|
Hyperglycemia
|
+
|
-
|
-
|
-
|
-
|
+
|
33
|
S. theophylline
|
|
|
|
|
|
|
|
level (µg/mL) |
16.2 |
17.7 |
18.9 |
26.8 |
21.6 |
24 |
|
S. Na, K, Ca |
Normal |
Normal |
Normal |
Normal |
Normal |
Normal |
|
CSF analysis |
Normal |
Normal |
Normal |
Normal |
Normal |
Normal |
|
Diagnosis |
Bronchiolitis |
Bronchiolitis |
Pneumonia |
Pneumonia |
Pneumonia |
Pneumonia |
|
Outcome |
Well |
Well |
Well |
Well |
Well |
Well |
|
The average pediatric serum half-life of
theophylline is slightly less than the average adult serum half-life
of four hours(2). The usual pediatric range is wide (2 to 12 hours)(3)
and varies inversely with age, being quite prolonged in premature
neonate. Correlations between serum theophylline levels and drug
toxicity in children are scanty. Therapeutic range of serum
theophylline levels were between 5-10 µg/mL in neonates and 10-15 µg/mL
in infants. In 1993 Powel EC(4) had observed that seizures developed
with a theophylline concentration of >50 µg/mL. In our study children
had CNS signs even at serum theophylline concentration between 15-30
µg/mL. This may be due to the variation in time interval between
theophylline administration and serum sampling of theophylline levels.
In our study we could not assess the actual time interval between
theophylline administration and serum. sampling for theophylline as
all children were treated for ARI with theophylline preparations
elsewhere before admission.
Douglas Baker had documented increased
predisposition for theophylline toxicity in children with viral
respiratory infection(5). 23% of their cases of theophylline toxicity
occurred in children with respiratory infection receiving appropriate
amount of theophylline. Most of our cases also had probable viral
respiratory infection predisposing to theophylline toxicity.
Our observation highlights the possibility of
theophylline over dosage in young infants treated for acute
respiratory infection presenting with CNS excitation symptoms. Care
should be taken to ensure appropriate dosage and frequency when
administering theophylline preparations to young infants with
respiratory infection.
T. Sathish Kumar,
Prabhakar D. Moses,*
Department of Child Health Unit III,
Christian Medical College,
Vellore 632 004, India.
*Corresponding author:
E-mail:
[email protected]
1. Vaucher Y, Lightner ES, Walson PD. Theophylline
poisoning. J Pediatr 1977; 90: 827- 830.
2. Weinberger M, Riegelman S. Rational use of
theophylline for bronchodilatation. N Engl J Med 1974; 291: 151-53.
3. Ellis EF, Yaffe SJ, Levy G. Pharmacokinetics of
theophylline in asthmatic children. J Allerg Clio Immun 1974; 53: 79.
4. Powell EC, Reynolds SL, Rubenstein JS.
Theophylline toxicity in children: a retrospective review. Pediatr
Emerg Care 1993; 3: 129-133.
5. Oslon KR, Benowitz NL, Woo OF, et al. Theophylline over
dosage: acute single ingestion versus chronic repeated over
medication. Am J Emerg Med 1985; 3: 386-394.
|